Clinical Trial

Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)

Name: Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG) — clinical trial record (NCT07556120)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open label, single arm study, to evaluate safety, tolerability and preliminary efficacy of HN2301 in patients with Generalized Myasthenia Gravis.

Protocol Amendment History 1 change

minor Completion pushed: 2027-12-31 -> 2028-12-31 2026-08-13

Trial Details

NCT Number	NCT07556120
Lead Sponsor	Shenzhen MagicRNA Biotechnology Co., Ltd Collaborators: The First Affiliated Hospital of University of Science and Technology of China
Conditions	Generalized Myasthenia Gravis
Enrollment	6 participants
Start Date	2026-12-31
Primary Completion	2027-05-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-12